Clinical Trial Update: A Phase II Safety and Tolerability Study of Bevacizumab When Added to Single-agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain [Phase 2]

View source ↗

Summary

A Phase II safety and tolerability trial evaluating adding bevacizumab to single-agent chemotherapy for breast cancer with brain metastases. The study was termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Duke University | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2013-07-17